Rep. Kevin Hern Unloads Shares of Kenvue Inc. (NYSE:KVUE)

Posted by Geri Gentry on Aug 12th, 2026

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Kenvue Inc. (NYSE:KVUE). In a filing disclosed on August 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Kenvue stock on August 5th. The trade occurred in the Representative’s “HERN FAMILY FOUNDATION” account.

Representative Kevin Hern also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Diageo (NYSE:DEO) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Estee Lauder Companies (NYSE:EL) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Organon & Co. (NYSE:OGN) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Mondelez International (NASDAQ:MDLZ) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Versant (NASDAQ:VSNT) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Comcast (NASDAQ:CMCSA) on 8/5/2026.

Kenvue Price Performance

KVUE stock opened at $19.09 on Wednesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. The company’s 50-day moving average is $18.83 and its 200-day moving average is $18.12. The stock has a market capitalization of $36.66 billion, a PE ratio of 21.94, a price-to-earnings-growth ratio of 1.36 and a beta of 0.47. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $21.95.

Kenvue (NYSE:KVUE – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. During the same period last year, the company posted $0.29 earnings per share. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. Equities research analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be given a dividend of $0.21 per share. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. Kenvue’s payout ratio is currently 95.40%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Wall Street Zen cut shares of Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday. UBS Group decreased their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Tuesday. Citigroup dropped their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Finally, Barclays upped their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus price target of $19.27.

Check Out Our Latest Stock Report on Kenvue

Institutional Trading of Kenvue

A number of large investors have recently added to or reduced their stakes in the stock. CoreCap Advisors LLC grew its stake in Kenvue by 64.9% during the 2nd quarter. CoreCap Advisors LLC now owns 1,502 shares of the company’s stock valued at $29,000 after purchasing an additional 591 shares during the last quarter. Montag A & Associates Inc. raised its stake in shares of Kenvue by 6.3% in the first quarter. Montag A & Associates Inc. now owns 10,156 shares of the company’s stock worth $175,000 after purchasing an additional 600 shares during the last quarter. Cornerstone Wealth Group LLC raised its stake in shares of Kenvue by 5.9% in the first quarter. Cornerstone Wealth Group LLC now owns 10,810 shares of the company’s stock worth $187,000 after purchasing an additional 606 shares during the last quarter. Physician Wealth Advisors Inc. lifted its holdings in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after purchasing an additional 618 shares during the period. Finally, Mill Creek Capital Advisors LLC boosted its position in Kenvue by 0.6% in the fourth quarter. Mill Creek Capital Advisors LLC now owns 124,213 shares of the company’s stock valued at $2,143,000 after buying an additional 701 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

Kenvue Company Profile

(Get Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.